Emmanuel Tupin

Title: Emmanuel Tupin: Innovator in Mycobacterial Antigen Vaccines

Introduction

Emmanuel Tupin is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of immunology, particularly in the development of vaccines targeting mycobacterial infections. His innovative work has the potential to enhance the effectiveness of immune responses against various diseases.

Latest Patents

Emmanuel Tupin holds a patent for a mycobacterial antigen vaccine. This invention relates to immunogenic combinations that comprise at least five antigens of a species, along with their fusion and nucleic acid molecules encoding these combined antigens. The patent also covers vectors, host cells, and compositions that include these combinations of mycobacterial antigens and fusion polypeptides. Furthermore, it outlines methods for recombinantly producing these components and their applications in inducing immune responses against infections caused by mycobacteria.

Career Highlights

Emmanuel Tupin is associated with Transgene S.A., a company that focuses on developing innovative immunotherapies. His work at Transgene has allowed him to collaborate with other experts in the field, contributing to advancements in vaccine technology.

Collaborations

Some of Emmanuel Tupin's notable coworkers include Romain Micol and Charles Antoine Coupet. Their collaborative efforts have furthered research and development in the area of immunogenic vaccines.

Conclusion

Emmanuel Tupin's contributions to the field of immunology, particularly through his patent on mycobacterial antigen vaccines, highlight his role as an innovator. His work has the potential to significantly impact the diagnosis and treatment of infections caused by mycobacteria.